Skip to main content
. 2010 Jan 14;25(10):2035–2048. doi: 10.1007/s00467-009-1386-4

Fig. 4.

Fig. 4

Cedars-Sinai Medical Center protocol for treating antibody-mediated rejection (AMR) that is C4d+. After AMR diagnosis by biopsy, patients are treated with pulse Solumedrol (SM) (10 mg/kg) daily × 3 on day 1 and intravenously administered immunoglobulin (IVIG) 2 g/kg (maximum dose 140 g), followed on day 2 by rituximab 375 mg/m2 . A repeat IVIG dose is usually given at 30–60 days after AMR diagnosis